Syndax Pharmaceuticals Financial Overview
Syndax Pharmaceuticals's market cap is currently $1.88B. The company's EPS TTM is $-0.7; its P/E ratio is -5.97; Syndax Pharmaceuticals is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
